MissionIR Articles

  • Gulf Resources (GURE) Presents at Rodman & Renshaw Conference

    Gulf Resources, Inc. (NASDAQ: GURE) operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and ShouguangYuxin Chemical Industry Co., Limited (“SYCI”). The company believes that it is one of the largest producers…

  • Great Panther Silver (GPL) Presents at Rodman & Renshaw Conference

    Great Panther Silver Ltd. (NYSE: GPL) is a primary silver mining and exploration company whose current activities are focused on the mining of precious metals from its two whollyowned mining operations in Mexico: the Guanajuato…

  • GeoVax Labs (GOVX) Presents at Rodman & Renshaw Conference

    GeoVax Labs, Inc. (OTC: GOVX) is a clinical-stage biotechnology company developing innovative human vaccines using its novel VLP (virus-like particle) platform technology. The company’s proprietary vaccine technology has been developed through multi-year collaborations with the…

  • GenSpera (GNSZ) Presents at Rodman & Renshaw Conference

    GenSpera, Inc. (OTC: GNSZ) is a biotechnology company focused on the development and commercialization of promising, new therapeutics. GenSpera combines powerful insights and rigorous scientific methods to create new treatment options for patients. The company’s…

  • General Moly (GMO) Presents at Rodman & Renshaw Conference

    U.S.-based General Moly, Inc. (NYSE: GMO) is a mineral company engaged in the exploration, development and mining of molybdenum (”moly”). The company owns two world-class moly projects located in Nevada, U.S.; an 80% interest in…

  • Galena Biopharma (GALE) Presents at Rodman & Renshaw Conference

    Galena Biopharma, Inc. (NASDAQ: GALE) is developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets,…

  • Great Basin Scientific (GBSN) Presents at Rodman & Renshaw Conference

    Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular…

  • Galectin Therapeutics (GALT) Presents at Rodman & Renshaw Conference

    Georgia-based Galectin Therapeutics, Inc. (NASDAQ: GALT) is a biotechnology company focused on discovery and development. The company applies its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer.…

  • Fusion Telecommunications International (FSNN) Presents at Rodman & Renshaw Conference

    Fusion Telecommunications International, Inc. (NASDAQ: FSNN),in concert with its subsidiaries, provides cloud communications, cloud connectivity, cloud computing, and managed cloud-based solutions to small, medium, and large businesses worldwide. The company also offers voice services to…

  • Global Blood Therapeutics (GBT) Presents at Rodman & Renshaw Conference

    Global Blood Therapeutics, Inc. (NASDAQ: GBT) is a clinical stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. GBT is developing its initial product…

  • FlexShopper (FPAY) Presents at Rodman & Renshaw Conference

    FlexShopper, Inc. (OTC: FPAY) provides a flexible and easy way for consumer to get furniture, electronics, appliances and other popular brand name goods through low, affordable weekly payments. The company’s goal is to get customers…

  • Flex Pharma (FLKS) Presents at Rodman & Renshaw Conference

    The biotechnology company Flex Pharma, Inc. (NASDAQ: FLKS) is developing innovative and proprietary treatments for exercise-associated muscle cramps, nocturnal leg cramps, and spasms associated with severe neuromuscular conditions. Flex Pharma’s products will be designed to…

  • Finjan Holdings (FNJN) Presents at Rodman & Renshaw Conference

    Finjan Holdings, Inc. (NASDAQ: FNJN) offers investors a diversified and unique vehicle for investing in cybersecurity-related intellectual property-backed technologies under the guidance of a proven team. Finjan’s commitment to innovation in the security space continues…

  • Fate Therapeutics (FATE) Presents at Rodman & Renshaw Conference

    Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases. The company is primarily focused on developing programmed hematopoietic cellular…

  • Eyegate Pharmaceuticals (EYEG) Presents at Rodman & Renshaw Conference

    Eyegate Pharmaceuticals, Inc. (OTC: EYEG), a late-stage specialty pharmaceutical and drug delivery company, is working on developing and commercializing therapeutics and drug delivery mechanisms for treating eye diseases. The company’s technology addresses two of the…

  • EuroSite Power (EUSP) Presents at Rodman & Renshaw Conference

    EuroSite Power, Inc. (OTC: EUSP) is a majority-owned subsidiary of American DG Energy, and has been established to expand its successful on-site utility business into the United Kingdom and Europe. The company sells the energy…

  • Energy Fuels (UUUU) Presents at Rodman & Renshaw Conference

    Energy Fuels, Inc. (NYSE: UUUU) is America’s premier integrated uranium miner. Uranium is the fuel for nuclear, which is the true “green energy” as it provides emission-free and carbon-free electricity. Energy Fuels is positioned as…

  • Emisphere Technologies (EMIS) Presents at Rodman & Renshaw Conference

    Emisphere Technologies, Inc. (EMIS) is a specialty pharmaceutical company that recently commenced commercial operations. The company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the company…

  • Emisphere Technologies, Inc. (EMIS) Presents at Rodman & Renshaw Conference

    Emisphere Technologies, Inc. (OTCBB: EMIS), a commercial stage, specialty pharmaceutical company, is currently preparing to launch its first prescription product, oral Eligen B12, in the United States. Beyond Eligen B12, the company employs its proprietary…

  • eMagin (EMAN) Presents at Rodman & Renshaw Conference

    eMagin Corporation (NYSE: EMAN) is a leading manufacturer of active-matrix Organic LED (AM-OLED) microdisplays on silicon. These displays perform at low-power levels, extended temperature ranges and provide image performance not possible with LCD technologies. The…